Advagene Biopharma Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced operating loss was TWD 75.793 million compared to TWD 98.844 million a year ago. Net loss was TWD 70.162 million compared to TWD 91.615 million a year ago.